Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Acrocephalosyndactylia × lenvatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 7 Neoplasms 2 Urologic Neoplasms 1 Sarcoma, Kaposi 1 Hepatitis B 1 GBM 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Hepatocellular Carcinoma 1 Acrocephalosyndactylia 1

Interventions

lenvatinib 1 infigratinib 1 Rabeprazole 1 E-3810 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02846766 2018-08-02

Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling

University of California, San Diego

Phase 2 Withdrawn

Acrocephalosyndactylia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡